ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 10.50
-0.40 (-3.67%)
Sep 4, 2026, 1:27 PM CET
ViroGates Market Cap
ViroGates has a market cap or net worth of 97.46 million as of September 4, 2026. Its market cap has increased by 24.76% in one year.
Market Cap
97.46M
Enterprise Value
83.76M
Revenue
9.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.50
ChartMarket Cap Chart
Since June 26, 2018, ViroGates's market cap has decreased from 259.22M to 97.46M, a decrease of -62.40%. That is a compound annual growth rate of -11.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 97.46M | -21.93% |
| Dec 30, 2025 | 124.84M | 52.27% |
| Dec 30, 2024 | 81.99M | 111.23% |
| Dec 29, 2023 | 38.81M | -71.09% |
| Dec 30, 2022 | 134.25M | -70.57% |
| Dec 30, 2021 | 456.12M | 79.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.32T |
| Genmab | 129.25B |
| Coloplast | 102.38B |
| Demant | 61.54B |
| Gubra | 5.93B |
| BioPorto | 591.66M |
| Pharma Equity Group | 101.64M |
| Scandinavian Medical Solutions | 71.46M |